Artivion [AORT] vs Procept BioRobotics [PRCT] Detailed Stock Comparison
Artivion
NYSE
Loading...
Procept BioRobotics
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Artivion wins in 13 metrics, Procept BioRobotics wins in 5 metrics, with 0 ties. Artivion appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Artivion | Procept BioRobotics | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -128.47 | -19.85 | Artivion |
| Price-to-Book Ratio | 4.75 | 5.14 | Artivion |
| Debt-to-Equity Ratio | 62.81 | 20.57 | Procept BioRobotics |
| PEG Ratio | 0.80 | 0.66 | Procept BioRobotics |
| EV/EBITDA | 48.19 | -20.51 | Procept BioRobotics |
| Profit Margin (TTM) | -4.43% | -30.60% | Artivion |
| Operating Margin (TTM) | 9.72% | -28.02% | Artivion |
| EBITDA Margin (TTM) | 9.72% | N/A | N/A |
| Return on Equity | -5.02% | -26.40% | Artivion |
| Return on Assets (TTM) | 1.70% | -12.93% | Artivion |
| Free Cash Flow (TTM) | $11.05M | $-103.62M | Artivion |
| Dividend Yield | N/A | 0.64% | N/A |
| 1-Year Return | 53.48% | -52.11% | Artivion |
| Price-to-Sales Ratio (TTM) | 4.93 | 7.42 | Artivion |
| Enterprise Value | $2.19B | $1.76B | Artivion |
| EV/Revenue Ratio | 5.42 | 6.41 | Artivion |
| Gross Profit Margin (TTM) | 64.72% | 65.35% | Procept BioRobotics |
| Revenue per Share (TTM) | $10 | $5 | Artivion |
| Earnings per Share (Diluted) | $-0.44 | $-1.50 | Artivion |
| Beta (Stock Volatility) | 1.70 | 1.03 | Procept BioRobotics |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Artivion vs Procept BioRobotics Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Artivion | -1.26% | 0.40% | -7.14% | 31.57% | 62.04% | 44.55% |
| Procept BioRobotics | 0.20% | -6.00% | -12.05% | -40.19% | -39.73% | -58.15% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Artivion | 53.48% | 250.13% | 110.15% | 296.68% | 555.57% | 472.36% |
| Procept BioRobotics | -52.11% | -13.09% | -13.00% | -13.00% | -13.00% | -13.00% |
News Based Sentiment: Artivion vs Procept BioRobotics
Artivion
News based Sentiment: MIXED
October was a mixed month for Artivion, with a significant earnings beat and positive analyst revisions offset by notable insider selling and fluctuating stock performance. The combination of positive financial results and concerning insider activity creates a complex investment narrative, making it a moderately important month for investors.
Procept BioRobotics
News based Sentiment: MIXED
September presented a mixed bag for Procept BioRobotics, with strong Q2 earnings and positive analyst ratings countered by stock volatility, insider selling, and downward price target revisions. The conflicting signals create a complex investment picture, making it a significant month for the company's trajectory.
Performance & Financial Health Analysis: Artivion vs Procept BioRobotics
| Metric | AORT | PRCT |
|---|---|---|
| Market Information | ||
| Market Cap | $1.94B | $1.99B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 469,077 | 902,800 |
| 90 Day Avg. Volume | 440,382 | 951,347 |
| Last Close | $40.59 | $34.80 |
| 52 Week Range | $21.97 - $45.07 | $34.01 - $103.81 |
| % from 52W High | -9.94% | -66.48% |
| All-Time High | $45.07 (Aug 22, 2025) | $103.81 (Nov 11, 2024) |
| % from All-Time High | -9.94% | -66.48% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.48% |
| Quarterly Earnings Growth | 0.15% | 0.48% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | -0.31% |
| Operating Margin (TTM) | 0.10% | -0.28% |
| Return on Equity (TTM) | -0.05% | -0.26% |
| Debt to Equity (MRQ) | 62.81 | 20.57 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.91 | $6.94 |
| Cash per Share (MRQ) | $1.13 | $5.44 |
| Operating Cash Flow (TTM) | $19.65M | $-83,214,000 |
| Levered Free Cash Flow (TTM) | $-12,697,875 | $-59,140,124 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.64% |
| Last 12-Month Dividend | $0.00 | $0.38 |
Valuation & Enterprise Metrics Analysis: Artivion vs Procept BioRobotics
| Metric | AORT | PRCT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -128.47 | -19.85 |
| Forward P/E | 176.31 | -26.83 |
| PEG Ratio | 0.80 | 0.66 |
| Price to Sales (TTM) | 4.93 | 7.42 |
| Price to Book (MRQ) | 4.75 | 5.14 |
| Market Capitalization | ||
| Market Capitalization | $1.94B | $1.99B |
| Enterprise Value | $2.19B | $1.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.42 | 6.41 |
| Enterprise to EBITDA | 48.19 | -20.51 |
| Risk & Other Metrics | ||
| Beta | 1.70 | 1.03 |
| Book Value per Share (MRQ) | $8.91 | $6.94 |
Financial Statements Comparison: Artivion vs Procept BioRobotics
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AORT | PRCT |
|---|---|---|
| Revenue/Sales | $112.97M | $69.16M |
| Cost of Goods Sold | $39.86M | $25.00M |
| Gross Profit | $73.11M | $44.16M |
| Research & Development | $7.06M | $16.40M |
| Operating Income (EBIT) | $8.38M | $-27.44M |
| EBITDA | $18.95M | $-22.39M |
| Pre-Tax Income | $3.48M | $-24.74M |
| Income Tax | $2.14M | N/A |
| Net Income (Profit) | $1.35M | $-24.74M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AORT | PRCT |
|---|---|---|
| Cash & Equivalents | $37.69M | $316.21M |
| Total Current Assets | $287.30M | $465.79M |
| Total Current Liabilities | $51.94M | $52.06M |
| Long-Term Debt | $356.98M | $77.83M |
| Total Shareholders Equity | $294.25M | $389.16M |
| Retained Earnings | $-61.77M | $-570.72M |
| Property, Plant & Equipment | $77.04M | $21.26M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AORT | PRCT |
|---|---|---|
| Operating Cash Flow | $-17.94M | $-11.65M |
| Capital Expenditures | N/A | $-1.84M |
| Free Cash Flow | $-20.59M | $-18.82M |
| Debt Repayment | $-66,000 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AORT | PRCT |
|---|---|---|
| Shares Short | 1.08M | 8.15M |
| Short Ratio | 2.52 | 8.52 |
| Short % of Float | 0.03% | 0.17% |
| Average Daily Volume (10 Day) | 469,077 | 902,800 |
| Average Daily Volume (90 Day) | 440,382 | 951,347 |
| Shares Outstanding | 41.95M | 54.72M |
| Float Shares | 41.61M | 53.56M |
| % Held by Insiders | 0.05% | 0.05% |
| % Held by Institutions | 0.90% | 0.98% |
Dividend Analysis & Yield Comparison: Artivion vs Procept BioRobotics
| Metric | AORT | PRCT |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $0.38 |
| Last 12-Month Dividend Yield | N/A | 0.64% |
| 3-Year Avg Annual Dividend | $0.00 | $0.53 |
| 3-Year Avg Dividend Yield | N/A | 0.12% |
| 3-Year Total Dividends | $0.00 | $1.59 |
| Ex-Dividend Date | N/A | Mar 31, 2025 |